NO159104C - Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5. - Google Patents

Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5.

Info

Publication number
NO159104C
NO159104C NO831754A NO831754A NO159104C NO 159104 C NO159104 C NO 159104C NO 831754 A NO831754 A NO 831754A NO 831754 A NO831754 A NO 831754A NO 159104 C NO159104 C NO 159104C
Authority
NO
Norway
Prior art keywords
procedure
preparing pure
single factors
teichomycin
pure teichomycin
Prior art date
Application number
NO831754A
Other languages
English (en)
Other versions
NO831754L (no
NO159104B (no
Inventor
Angelo Borghi
Rosa Pallanza
Carolina Coronelli
Giovanni Cassani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO831754L publication Critical patent/NO831754L/no
Publication of NO159104B publication Critical patent/NO159104B/no
Publication of NO159104C publication Critical patent/NO159104C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO831754A 1982-06-08 1983-05-16 Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5. NO159104C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (3)

Publication Number Publication Date
NO831754L NO831754L (no) 1983-12-09
NO159104B NO159104B (no) 1988-08-22
NO159104C true NO159104C (no) 1988-11-30

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831754A NO159104C (no) 1982-06-08 1983-05-16 Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5.

Country Status (32)

Country Link
US (1) US4542018A (no)
JP (5) JPS591423A (no)
KR (1) KR900008246B1 (no)
AU (1) AU560966B2 (no)
BE (1) BE896993A (no)
BG (1) BG60529B2 (no)
CA (1) CA1208204A (no)
CH (1) CH657139A5 (no)
DE (1) DE3320342A1 (no)
DK (1) DK159117C (no)
ES (2) ES522941A0 (no)
FI (1) FI73697C (no)
FR (1) FR2528050B1 (no)
GB (1) GB2121401B (no)
GR (1) GR78267B (no)
HK (1) HK55887A (no)
HU (1) HU193538B (no)
IE (1) IE55025B1 (no)
IL (1) IL68819A0 (no)
IT (1) IT1212085B (no)
LU (1) LU84853A1 (no)
MY (1) MY8700002A (no)
NL (1) NL8301980A (no)
NO (1) NO159104C (no)
NZ (1) NZ204480A (no)
PH (1) PH19533A (no)
PT (1) PT76831B (no)
SE (1) SE459094B (no)
SG (1) SG70686G (no)
SU (1) SU1318170A3 (no)
UA (1) UA6025A1 (no)
ZA (1) ZA833607B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
HUT63860A (en) * 1990-12-05 1993-10-28 Lepetit Spa Process for producing 39-decarboxy-38-(hydroxymethyl) derivatives of teikoplanin antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US6218505B1 (en) 1996-04-23 2001-04-17 Biosearch Italia S.P.A. Chemical process for preparing amide derivatives of antibiotic A 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050130909A1 (en) 2002-11-18 2005-06-16 Luigi Colombo Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IL68819A0 (en) 1983-09-30
PT76831A (en) 1983-07-01
KR900008246B1 (ko) 1990-11-06
DK159117C (da) 1991-02-11
JPH02291278A (ja) 1990-12-03
GR78267B (no) 1984-09-26
AU1496883A (en) 1983-12-15
GB2121401A (en) 1983-12-21
BG60529B2 (bg) 1995-07-28
IE831329L (en) 1983-12-08
JPH0224278B2 (no) 1990-05-29
FI831660A0 (fi) 1983-05-12
PT76831B (en) 1986-04-09
AU560966B2 (en) 1987-04-30
JPH0517237B2 (no) 1993-03-08
CA1208204A (en) 1986-07-22
JPH0517236B2 (no) 1993-03-08
MY8700002A (en) 1987-12-31
NO831754L (no) 1983-12-09
JPH02291279A (ja) 1990-12-03
SE459094B (sv) 1989-06-05
NL8301980A (nl) 1984-01-02
DK245883D0 (da) 1983-05-31
JPS591423A (ja) 1984-01-06
NO159104B (no) 1988-08-22
NZ204480A (en) 1986-04-11
GB2121401B (en) 1985-09-18
JPH0415238B2 (no) 1992-03-17
SU1318170A3 (ru) 1987-06-15
DE3320342C2 (no) 1991-07-11
FI73697C (fi) 1987-11-09
BE896993A (fr) 1983-12-07
SE8303211L (sv) 1983-12-09
FR2528050B1 (fr) 1987-03-20
ES536770A0 (es) 1985-08-16
US4542018A (en) 1985-09-17
DK245883A (da) 1983-12-09
CH657139A5 (fr) 1986-08-15
FI831660L (fi) 1983-12-09
DK159117B (da) 1990-09-03
PH19533A (en) 1986-05-20
ES8503689A1 (es) 1985-04-01
GB8315003D0 (en) 1983-07-06
ZA833607B (en) 1984-03-28
UA6025A1 (uk) 1994-12-29
KR840005170A (ko) 1984-11-05
FR2528050A1 (fr) 1983-12-09
HK55887A (en) 1987-08-07
SG70686G (en) 1987-07-03
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
ES522941A0 (es) 1985-04-01
SE8303211D0 (sv) 1983-06-07
ES8506748A1 (es) 1985-08-16
HU193538B (en) 1987-10-28
IT8321432A0 (it) 1983-06-02
JPH0415237B2 (no) 1992-03-17
DE3320342A1 (de) 1983-12-08
JPH02288887A (ja) 1990-11-28
JPH02288888A (ja) 1990-11-28
LU84853A1 (fr) 1984-03-07
FI73697B (fi) 1987-07-31

Similar Documents

Publication Publication Date Title
NO159104C (no) Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5.
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
DK316784A (da) 1,2,4-triazol-3-on-derivater og fremgangsmaade til fremstilling deraf
DK574581A (da) Delta2-1,2,4-triazolin-5-on-derivater og fremgangsmaade til fremstilling heraf
EP0092786A3 (en) 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
DE3176681D1 (en) 6- and 4-substituted-1-azabicyclo(3.2.0)heptan-3,7-dione-2-carboxylates
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
ZA832903B (en) 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
DK141383D0 (da) Substituerede 3,4-diamino-1,2,5-thiadiazoler og fremgangsmade til fremstilling deraf
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
IT1172389B (it) 2,2,2-trialogeno-1-(trialogenometil)etiliden-bis-benzen-tioli
FI821046A0 (fi) Foerfarande foer framstaellning av -(3,4,5-trimetoxibenzoyltio)-propionylglycin
ZA814392B (en) 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms
JPS57123182A (en) 6- and 4-substituted-1-azabicyclo(3,1,2,0)heptane- 3,7-dione-2-carboxylate
IL70193A0 (en) 1,1-disubstituted-2-heterocyclic ethanol derivatives
NO864307D0 (no) Fremgangsmaate for fremstilling av 5-heterocycliske-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
FI832262L (fi) Foerfarande foer framstaellning av 1-alkyl- eller 1,4-dialkyl-1h-pyrrol-2-aettiksyraestrar
DK191982A (da) 2,4-dioxacyklohexanonderivat og fremgangsmaade til fremstilling deraf
ZA832310B (en) 1,3,5-triacrylylhexahydro-s-triazine derivatives
NO163366C (no) Nytt 2-aminotiazolderivat og fremgangsmaate for fremstilling derav.
NO153922C (no) Flerlags sekk og fremgangsmaate for fremstiling av samme.
ATE24727T1 (de) 1,8-naphthyridine- und 1,5,8-azanaphthyridinederivate.
DK375484A (da) 3-hydroxy-26,26,26,27,27,27-hexafluor-cholest-5-en-25-ol-forbindelserog fremgangsmaade til fremstilling deraf
IT1161226B (it) 1,1-bis (2.3-diidrossibenzen) alchil - o - aril - metani e procedimento per la loro preparazione

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN MAY 2003